Literature DB >> 29084018

Assessing patient-reported outcomes in asthma and COPD patients: which can be recommended in clinical practice?

Janwillem W H Kocks1,2, Sven F Seys3, Titia S van Duin1,2, Zuzana Diamant1,2,4, Ioanna G Tsiligianni1,2,5.   

Abstract

PURPOSE OF REVIEW: There is a clear need for simple and reliable patient-reported outcome measures for chronic obstructive pulmonary disease (COPD) and asthma in daily practice. The purpose of this review is to facilitate the choice for clinicians of patient-reported outcomes which they can use in their daily practice. RECENT
FINDINGS: More than 50 patient-reported outcome measures for asthma and COPD exist and clinicians are often left confused on which to use. Four tools (two for asthma and two for COPD) can be suggested based on validity/reliability, responsiveness, practicality and are particularly convenient in terms of time to measure.
SUMMARY: On the basis of ample evidence, the COPD assessment test and the clinical COPD questionnaire for COPD and asthma control questionnaire and the asthma control test for asthma can be recommended for use in both primary care and other clinical settings. A simple guide figured as smiley faces has been designed to assist physicians to easily select the appropriate measure. With the current direction of thinking into treatable traits, targeted measures that evaluate the upper airways like the control of allergic rhinitis and asthma test may also be more used in the future.

Entities:  

Mesh:

Year:  2018        PMID: 29084018     DOI: 10.1097/MCP.0000000000000447

Source DB:  PubMed          Journal:  Curr Opin Pulm Med        ISSN: 1070-5287            Impact factor:   3.155


  4 in total

1.  Early Endotyping: A Chance for Intervention in Chronic Obstructive Pulmonary Disease.

Authors:  Hans Petersen; Rodrigo Vazquez Guillamet; Paula Meek; Akshay Sood; Yohannes Tesfaigzi
Journal:  Am J Respir Cell Mol Biol       Date:  2018-07       Impact factor: 6.914

2.  Improvement of patient-reported outcomes in severe allergic asthma by omalizumab treatment: the real life observational PROXIMA study.

Authors:  Giorgio Walter Canonica; Paola Rottoli; Caterina Bucca; Maria Cristina Zappa; Giovanni Michetti; Bruno Macciocchi; Cristiano Caruso; Pierachille Santus; Marta Bartezaghi; Laura Rigoni
Journal:  World Allergy Organ J       Date:  2018-11-01       Impact factor: 4.084

3.  Assessing the prevalence and severity of asthma, rhinitis, and eczema among schoolchildren (6-7 and 13-14 years old) in Khuzestan, Iran: a cross-sectional survey.

Authors:  Maryam Dastoorpoor; Narges Khodadadi; Farzan Madadizadeh; Hanieh Raji; Elham Shahidizadeh; Esmaeil Idani; Maryam Haddadzadeh Shoushtari
Journal:  BMC Pediatr       Date:  2022-08-02       Impact factor: 2.567

Review 4.  The asthma evidence base: a call for core outcomes in interventional trials.

Authors:  Vickram Tejwani; Hsing-Yuan Chang; Annie P Tran; Rachael M Moloney; Sumita B Khatri
Journal:  J Asthma       Date:  2020-04-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.